Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IndividualfiledCriticalIndividual
Priority to JP55132795ApriorityCriticalpatent/JPS5758627A/en
Publication of JPS5758627ApublicationCriticalpatent/JPS5758627A/en
Publication of JPS6366289B2publicationCriticalpatent/JPS6366289B2/ja
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines Containing Plant Substances
(AREA)
Abstract
PURPOSE: A proteinic biosynthetic accelerator, containing an aconitine alkaloid as an active constituent, and useful for accelerating the biosynthesis of proteins.
CONSTITUTION: A proteinic biosynthetic accelerator containing one of aconitine alkaloid selected from the group consisting of mesacorntine, aconitine and hypaconitine or a mixture of two or more thereof. Experiments on the measurement of the amount incorporated of 3H-leucine into hepatic proteins showed that the proteinic biosynthesis was significantly accelerated by the administration of an aconite root containing the mesaconitine, aconitine, hypaconitine or an aconitine alkaloid or a processed aconite root. The daily dose at the proteinic biosynthetic accelerator is 0.1g aconite root powder, 10g processed aconite powder, 0.12mg mesaconitine, 0.15mg aconitine and 0.45mg hypaconitine for an adult by the oral administration.
Process for the preparation of analgesic compositions containing 17-(cyclopropylmethyl)-x-(1,1-dimethyethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-6,14-ethenomorphinane-7-methanol and 1-n-alyl-14-hydroxynordihydromorphinone
New derivatives of 3-keto delta 4,9,19-nor steroids,their preparation,their application as medicaments,the compositions containing them and the new intermediates obtained
Process for the preparation of imidazo-<1,2-c>pyrazolio-<3,4-e>-pyrimidines with antipsychotic effect and pharmaceutical compositions therewith
Fluoroalkyl-1'-di-halobenzyl-spiro(imidazolidine-4,3'-indoline)-2,2',5-triones,their preparation and pharmaceutical compositions containing them
Compound 3-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxopurine-7-acetyl-8-(2-phenylethyl)-1-oxa-3,8-diazaspiro-(4,5)decan-2-one and a process of preparation thereof